Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
598.00    1.00 (0.17%)
Bid:
596.00
Ask:
599.00
Spread: 3.00 (0.503%)
Market Cap: £1.10b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

PDMR / PCA Dealing

15 Mar 2022 11:14

RNS Number : 8331E
Volex PLC
15 March 2022
 

15 March 2022

 

Volex plc

("Volex" or the "Company")

 

PDMR / PCA Dealing 

 

Volex plc (AIM:VLX) announces that it was notified on 15 March 2022 that Mrs Sharon Molloy, wife of John Molloy, Chief Operating Officer and PDMR, purchased 95,000 Ordinary Shares of 25 pence in the Company ("Ordinary Shares") on 14 March 2022, at a weighted average price of 261.98 pence per Ordinary Share.

Following this purchase, the combined beneficial holding of John Molloy and his wife is 2,295,700 Ordinary Shares in total, representing 1.45% of the issued share capital of the Company.

The following disclosure is made in accordance with Article 19 of the UK version of the EU Market Abuse Regulation 596/2014 which has effect in English law by virtue of the European Union (Withdrawal) Act 2018.

 

NOTIFICATION OF TRANSACTIONS BY DIRECTORS / PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED

 

1

Details of the Director / person discharging managerial responsibilities / person closely associated 

a)

Name

Sharon Molloy

2

Reason for the notification

a)

Position/status

PCA with John Molloy (Chief Operating Officer, a PDMR of the Company)

b)

Initial notification / Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

Volex plc

b)

LEI

213800HBLQNH5FXXGE63

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument 

Ordinary Shares of 25 pence each

Identification code 

GB0009390070

b)

Nature of the transactions

Purchase of Ordinary Shares

c)

Price(s) and volume(s) 

Price (s)

Volume (s)

£2.61994

90,000

£2.61758

5,000

 

d)

Aggregated information 

- Aggregated volume

95,000

- Price

£248,882.50

e)

Date of the transactions

14 March 2022

f)

Place of the transactions

AIMX

 

For further information please contact:

Volex plc

+44 (0)7971 156 431

Nat Rothschild, Executive Chairman

 

Jon Boaden, Chief Financial Officer

 

Christian Bedford, Group General Counsel and Company Secretary

 

 

Singer Capital Markets - Nominated Adviser & Joint Broker

+44 (0)20 7496 3000

Shaun Dobson

 

George Tzimas

 

 

HSBC Bank plc - Joint Broker

+44 (0)20 7991 8888

Simon Alexander

 

Joe Weaving

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUWGWUPPGGA
Date   Source Headline
17th Mar 20163:52 pmRNSDirector/PDMR Shareholding
26th Feb 20169:44 amRNSDirector/PDMR Shareholding
26th Feb 20167:00 amRNSTrading Statement
21st Dec 20158:00 amRNSManagement changes
27th Nov 20157:00 amRNSDirectorate Change
16th Nov 20152:46 pmRNSChange of Adviser
12th Nov 20158:00 amRNSHalf Yearly Report
11th Nov 20159:30 amRNSDirector Declaration
9th Nov 20153:37 pmRNSDirector Declaration
19th Oct 201511:41 amRNSHolding(s) in Company
15th Oct 20157:00 amRNSAppointment of Non-Executive Director
2nd Oct 20158:21 amRNSDirector/PDMR Shareholding
1st Oct 20151:11 pmRNSHolding(s) in Company
30th Sep 20157:00 amRNSDirector/PDMR Shareholding
29th Sep 20151:00 pmRNSBoard Change and Trading Update
24th Jul 201512:54 pmRNSAGM Statement
26th Jun 20157:00 amRNSAnnual Report and Notice of AGM
18th Jun 201510:18 amRNSDirector/PDMR Shareholding
11th Jun 20157:00 amRNSPreliminary results for year ended 5 April 2015
8th Jun 20159:32 amRNSDirectorate Change
26th May 201512:01 pmRNSHolding(s) in Company
15th Apr 20157:00 amRNSAppointment of Non-Executive Director
27th Mar 20157:00 amRNSTrading Update
10th Mar 201510:55 amRNSHolding(s) in Company
9th Mar 20152:30 pmRNSHolding(s) in Company
20th Feb 20153:05 pmRNSDirector/PDMR Shareholding
4th Feb 201511:02 amRNSHolding(s) in Company
4th Feb 20158:30 amRNSHolding(s) in Company
30th Dec 20147:00 amRNSDirectorate Change
19th Dec 201412:00 pmRNSDirector/PDMR Shareholding
11th Dec 20147:00 amRNSBoard Change
8th Dec 201411:48 amRNSHolding(s) in Company
14th Nov 20141:45 pmRNSHolding(s) in Company
13th Nov 20143:52 pmRNSDirector/PDMR Shareholding
13th Nov 20141:49 pmRNSDirector/PDMR Shareholding
13th Nov 20147:00 amRNSVolex plc - Half year results to 5 October 2014
31st Oct 20143:05 pmRNSHolding(s) in Company
12th Sep 20144:23 pmRNSReplacement Director/PDMR Shareholding
12th Sep 201412:33 pmRNSDirector/PDMR Shareholding
21st Aug 201411:38 amRNSHolding(s) in Company
28th Jul 201411:01 amRNSDirector/PDMR Shareholding
21st Jul 201410:17 amRNSDirector/PDMR Shareholding
18th Jul 201411:03 amRNSResult of AGM
18th Jul 20149:39 amRNSAGM Statement
15th Jul 201410:08 amRNSDirector/PDMR Shareholding
14th Jul 201411:40 amRNSHolding(s) in Company
3rd Jul 20144:47 pmRNSHolding(s) in Company
3rd Jul 20142:59 pmRNSHolding(s) in Company
1st Jul 20141:55 pmRNSResult of General Meeting
1st Jul 20147:01 amRNSPublication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.